Modern Lab gets MP Govt nod to manufacture black fungus drug Amphotericin B

Published On 2021-05-31 04:00 GMT   |   Update On 2021-05-31 04:00 GMT
Advertisement

Indore: The Madhya Pradesh government has given permission to the Indore-based Modern Laboratories to manufacture Amphotericin B drug used in the treatment of Black Fungus, White Fungus, and Yellow Fungus.

"The government gave the permission within 72 hours. Now, we will start production and start supplying injections in the market in 15 days," said Anil Kharia, Chairman, Modern Laboratories on Sunday.

Advertisement

Also Read: Zydus Cadila, TLC collaborate for AmphoTLC to treat Black Fungus in India

"We will work with a capacity of manufacturing 10,000 injections daily and our priority will be to give them first to Madhya Pradesh and then to other states. This injection will be in the emulsion form. The price in the market will be around Rs 3,000, while we will give the government around Rs 1,500," he said.

Currently, Modern Lab is manufacturing Posaconazole medicine as an alternative to Amphotericin B.

Worth mentioning, there is a shortage of Liposomal Amphotericin B injections used in the treatment of diseases such as Black Fungus. About five such injections are given to each patient daily depending on their illness and body weight, the total number of which ranges from 50 to 80 injections.

The death toll from the disease in Indore is also on the rise due to the shortage.

Tags:    
Article Source : ANI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News